Cost-effectiveness of newer technologies for the diagnosis of Mycobacterium tuberculosis infection in Brazilian people living with HIV
Abstract Tuberculosis is the leading cause of death among people living with HIV (PLH). Preventive tuberculosis therapy reduces mortality in PLH, especially in those with a positive tuberculin skin test (TST). New, more specific technologies for detecting latent tuberculosis infection (LTBI) are now...
Guardado en:
Autores principales: | Ricardo E. Steffen, Marcia Pinto, Afranio Kritski, Anete Trajman |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5f8f1da8d54f4861a0c12b7c16259b2b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Diagnostic performance of the Abbott RealTime MTB assay for tuberculosis diagnosis in people living with HIV
por: Belén Saavedra, et al.
Publicado: (2021) -
Development of physiologically‐based pharmacokinetic models for standard of care and newer tuberculosis drugs
por: Helen Humphries, et al.
Publicado: (2021) -
Alzheimer's disease: Newer biomarkers
por: Ankit Dangi, et al.
Publicado: (2021) -
Tuberculosis preventive treatment in people living with HIV-Is the glass half empty or half full?
por: Olivia Oxlade, et al.
Publicado: (2021) -
History, evolution and newer perspectives of rabies vaccines
por: K. Vijayakumar, et al.
Publicado: (2021)